ZSX Medical
Philadelphia, US · Delaware LLC
Biotech
Founders & leadership
DM
Daniel MazzuccoCo-founder
RE
Rugart EricCo-founder
Board
LB
Louis BerardiBoard director
Reported raises · per SEC filings
Form D private placements$2.1M disclosed across 3 rounds · 2016–2019
▶$235.2KraisedJan 2020 · 3 investors · BiotechnologyRule 506(b)
▶$235.2KraisedJan 2020 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Daniel MazzuccoExecutive Officer, Director
- Louis BerardiDirector
- David AndersonDirector
- Gary ZebrowskiDirector
- Eric RugartExecutive Officer, Director
- Offering amount
- $2M
- Amount sold
- $235.2K
- Minimum investment
- $25K
- First sale
- Nov 2019
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
▶$239.2KraisedJul 2018 · 6 investors · BiotechnologyRule 506(b)
▶$239.2KraisedJul 2018 · 6 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- LOUIS BERARDIDirector
- DANIEL MAZZUCCOExecutive Officer, Director
- DAVID ANDERSONDirector
- ERIC RUGARTExecutive Officer, Director
- GARY ZEBROWSKIDirector
- Offering amount
- $1M
- Amount sold
- $239.2K
- Minimum investment
- $25K
- First sale
- Jul 2018
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
▶$1.6MraisedFeb 2017 · 22 investors · BiotechnologyRule 506(b)
▶$1.6MraisedFeb 2017 · 22 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Daniel MazzuccoExecutive Officer, Director
- Rugart EricExecutive Officer, Director
- Louis BerardiDirector
- Offering amount
- $2.6M
- Amount sold
- $1.6M
- Minimum investment
- $10K
- Proceeds to insiders
- $120K
- First sale
- Feb 2016
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 3 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2021 | $1.7M |
| National Science Foundation | Phase II | 2014 | $750K |
| National Science Foundation | Phase I | 2013 | $150K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- Who founded ZSX Medical?
- ZSX Medical was founded by Daniel Mazzucco, Rugart Eric.
- How much funding has ZSX Medical raised?
- ZSX Medical has disclosed $2.1M raised across 3 rounds.
- Where is ZSX Medical headquartered?
- ZSX Medical is headquartered in Philadelphia, US.